Expression of concern
Resistance to CDK4/6 inhibitors (CDK4/6i): The clinical usefulness of liquid biopsy in metastatic breast cancer (mBC)
Paper Information
Record ID:
34856
Author(s):
Journal:
Publication Date:
May 18, 2021
Retraction Date:
May 18, 2021
(4.5 years years ago)
Subjects:
Institutions:
- U.O.C. Territorial Oncology of Aprilia, Sapienza University of Rome, Aprilia, Italy
- BIOS SpA, Rome, Italy
- Division of Medical Oncology, Policlinico Umberto I, Roma, Italy
- Biostatistical Consultant, E-Campus University, Rome, Italy
- Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy
- Clinical and Molecular Medicine Department, Sapienza University of Rome, Rome, Italy
- Department of Medical and Surgical Sciences and Translational Medicine, Sapienza University of Rome - Sant'Andrea University Hospital, Rome, Italy
- U.O.C. Territorial Oncology of Aprilia, AUSL Latina, Sapienza University of Rome, Aprilia, Italy
Country:
🇮🇹 ItalyArticle Type:
Publisher:
American Society of Clinical Oncology
Open Access:
Yes
PubMed ID:
Not indexed in PubMed
Retraction PubMed ID:
Not indexed in PubMed
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1200/JCO.2021.39.15_suppl.1053Additional Notes:
date of EOC unknown;
Citations (0)
0
Total Citations0
Post-Retraction0
Pre-Retraction0
Same Day
No citations found for this paper.
Related Records
This article has multiple records in the database due to different notices:
Record #34855
Nov 30, 2021Quick Stats
Total Citations:
0
Years Since Retraction:
4.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025